[WP-20-1] 177Lutetium-labeled PSMA-617 treatment in castration resistant prostate cancer, a ten year experience at UC CHRISTUS Clinical Hospital, Santiago, Chile.
Abstract password authentication.The password is described on page 8 of the "WFNMB2022 Program"